Holen Sie sich die Stockscreener-App
5.12
1.73%
-0.09
Handel nachbörslich:
5.00
-0.12
-2.34%
Schlusskurs vom Vortag:
$5.21
Offen:
$5.24
24-Stunden-Volumen:
428.10K
Relative Volume:
0.72
Marktkapitalisierung:
$257.90M
Einnahmen:
$230.47M
Nettoeinkommen (Verlust:
$30.28M
KGV:
8.3934
EPS:
0.61
Netto-Cashflow:
$38.86M
1W Leistung:
-0.19%
1M Leistung:
+12.78%
6M Leistung:
+86.86%
1J Leistung:
+88.93%
1-Tages-Spanne:
$5.11
$5.415
1-Wochen-Bereich:
$4.88
$5.415
52-Wochen-Spanne:
$2.32
$6.07
Puma Biotechnology Inc Stock (PBYI) Company Profile
Firmenname
Puma Biotechnology Inc
Sektor
Branche
Telefon
(424) 248-6500
Adresse
10880 WILSHIRE BLVD., LOS ANGELES, CA
Vergleichen Sie PBYI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
5.12 | 262.43M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-09-28 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-10-08 | Herabstufung | Goldman | Neutral → Sell |
| 2019-05-10 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-01-17 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2019-01-03 | Herabstufung | Guggenheim | Buy → Neutral |
| 2018-11-19 | Hochstufung | Goldman | Sell → Neutral |
| 2018-11-02 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-09-17 | Eingeleitet | Goldman | Sell |
| 2018-05-11 | Bestätigt | Stifel | Buy |
| 2017-11-10 | Bestätigt | Citigroup | Buy |
| 2017-11-10 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | Bestätigt | Stifel | Buy |
| 2017-09-11 | Bestätigt | Credit Suisse | Outperform |
| 2017-07-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-06-06 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
Alle ansehen
Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten
Puma Biotechnology (NASDAQ:PBYI) Raised to Buy (B-) at Weiss Ratings - MarketBeat
What’s next for Puma Biotechnology Inc. stock price2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com
Leading vs lagging indicators on Puma Biotechnology Inc. performanceLong Setup & Accurate Technical Buy Alerts - newser.com
Published on: 2025-10-10 03:15:11 - newser.com
Analyzing drawdowns of Puma Biotechnology Inc. with statistical toolsJuly 2025 Weekly Recap & Fast Momentum Entry Tips - newser.com
Will Puma Biotechnology Inc. stock benefit from sector rotationMarket Trend Review & Free Reliable Trade Execution Plans - newser.com
Puma Biotechnology (NASDAQ:PBYI) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Momentum divergence signals in Puma Biotechnology Inc. chartJuly 2025 Market Mood & Safe Entry Momentum Tips - newser.com
Is Puma Biotechnology Inc. stock a safe investment in uncertain marketsSwing Trade & Daily Stock Momentum Reports - newser.com
Will Puma Biotechnology Inc. stock go up soonM&A Rumor & Safe Entry Point Identification - newser.com
Pattern recognition hints at Puma Biotechnology Inc. upsideCEO Change & Fast Momentum Entry Tips - newser.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635c4 - MarketScreener
Comparing Puma Biotechnology Inc. in custom built stock radarsJuly 2025 Retail & Daily Stock Trend Reports - newser.com
Live market analysis of Puma Biotechnology Inc.Trade Entry Summary & Fast Gain Stock Trading Tips - newser.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)October 2, 2025 - BioSpace
Puma Biotechnology reports inducement awards under Nasdaq listing rule - MarketScreener
Barclays Maintains a Sell Rating on Puma Biotechnology (PBYI) With a $2 PT - MSN
What Do Analysts Think About Puma Biotechnology (PBYI)? - MSN
What analysts say about Puma Biotechnology Inc stockEarnings Per Share Trends & Low Entry Investment Ideas - earlytimes.in
Using data tools to time your Puma Biotechnology Inc. exitEarnings Overview Summary & Accurate Intraday Trading Signals - newser.com
September 2025's Promising Penny Stocks Revealed - simplywall.st
Puma Biotechnology Inc Stock Analysis and ForecastLow Risk Investment Ideas & Free Stay Informed With Forecasts - earlytimes.in
Tools to monitor Puma Biotechnology Inc. recovery probabilityJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Is Puma Biotechnology Inc a good long term investmentExit Strategy Tips & Explosive Capital Gains - Early Times
Strs Ohio Purchases Shares of 141,900 Puma Biotechnology, Inc. $PBYI - Defense World
Puma Biotechnology Inc. stock outlook for YEARWeekly Gains Report & Accurate Entry/Exit Alerts - newser.com
Finanzdaten der Puma Biotechnology Inc-Aktie (PBYI)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):